This mini-review summarizes the current knowledge of IBD-CRC, focusing on the main mechanisms underlying its pathogenesis, and on the important role of immunomodulators and …

IBD发生CRC的风险是正常人群的2~4倍，约20%的IBD患者在发病10年内发生CRC，IBD发生癌变的平均病程为12年。 病程10年、20年、30年的UC患者发生癌变的比率分别为2%、8% …

Inflammatory bowel disease (IBD)-related colorectal cancer (CRC) is responsible for approximately 2% of the annual mortality from CRC overall, but 10-15% of the annual deaths …

2016年10月18日 · 伴异型增生，特别是重度异型增生的 UC 患者 CRC 发生风险最高（3 级）；推荐对 IBD 患者进行内镜监测及根据患者的危险因素进行个体化治疗（1 级）；结直肠切除术能 …

Chronic inflammation in patients with Inflammatory Bowel Disease (IBD) leads to an increased risk of colorectal cancer, small bowel cancer, intestinal lymphoma and cholangiocarcinoma. …

2023年11月9日 · 本研究旨在研究英国国家卫生服务 (NHS)中IBD-CRC患者的特征、 手术治疗 和结果。 利用CRC数据库中来自英国国家卫生服务体系 (English National Health Service)的人 …

Patients with inflammatory bowel disease (IBD) are at significantly increased risk of colorectal cancer (CRC), principally resulting from the pro-neoplastic effects of chronic intestinal …

2012年8月7日 · This review examines the literature relating to IBD-CRC, focusing on the incidence of IBD-CRC and examining potential risk factors including age at diagnosis, gender, …

2021年12月18日 · The cumulative impact of chronic inflammation in patients with inflammatory bowel diseases predisposes to the development of inflammatory bowel disease-associated …

Inflammatory bowel disease (IBD) is widely accepted as one of the important risk factors leading to colorectal cancer (CRC). IBD ranks as the third highest risk condition for CRC, behind only …